Development of lead compounds for trypanocidal drugs based on inhibitors targeted against parasite glycolysis

Project Information

QUINONES WILFREDO

Grant agreement ID: ICB1-CT-2001-80008

Project closed

Start date 1 June 2000

End date 30 November 2000

Funded under

• Programme for research, technological development and demonstration on "Confirming the international role of Community research,1998-2002"

Total cost € 31 200,00

EU contribution € 31 200,00

Coordinated by

CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY
Belgium

Objective

Cloning, over-expression of one gene of interest of Leishmania Mexican and validation as drug target (PGAM, FR).General training in Molecular Biology and work in the corresponding INCO project

Fields of science

• natural sciences › biological sciences › molecular biology

Programme(s)

• FP5-INCO 2 - Programme for research, technological development and demonstration on "Confirming the international role of Community research,1998-2002"

Topic(s)

• 1.2.1.-2. - Training for researchers

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY

• EU contribution: No data
• Address: 74,Avenue Hippocrate 74, ICP-TROP 74.39 ; 1200 BRUXELLES ; Belgium
• Total cost: No data